Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.99B | 55.99B | 57.88B | 56.75B | 69.38B | 64.94B |
Gross Profit | 14.82B | 14.82B | 16.24B | 13.08B | 13.43B | 11.60B |
EBITDA | 8.66B | 8.12B | 9.28B | 4.59B | 7.40B | 2.26B |
Net Income | 3.09B | 3.09B | 4.71B | 252.00M | 2.25B | -3.02B |
Balance Sheet | ||||||
Total Assets | 100.42B | 100.42B | 92.11B | 86.54B | 82.10B | 80.56B |
Cash, Cash Equivalents and Short-Term Investments | 4.91B | 4.91B | 3.78B | 6.07B | 5.34B | 3.60B |
Total Debt | 29.47B | 29.47B | 30.65B | 29.62B | 24.85B | 26.09B |
Total Liabilities | 65.08B | 65.08B | 59.77B | 57.79B | 53.24B | 53.91B |
Stockholders Equity | 33.91B | 33.91B | 30.94B | 25.10B | 25.25B | 23.07B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.32B | -2.32B | -3.70B | 1.90B | -279.00M |
Operating Cash Flow | 0.00 | 7.17B | 5.70B | 2.09B | 4.09B | 4.21B |
Investing Cash Flow | 0.00 | -8.56B | -8.50B | -5.59B | -548.00M | -4.38B |
Financing Cash Flow | 0.00 | 2.38B | 463.00M | 4.14B | -1.87B | 1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥12.88B | 10.44 | 1.30% | 8.41% | 3.21% | ||
77 Outperform | ¥10.77B | 11.80 | 2.46% | 7.00% | -28.12% | ||
76 Outperform | ¥17.63B | 10.99 | 2.66% | 9.52% | 17.71% | ||
75 Outperform | ¥10.49B | 13.68 | 4.30% | 1.25% | 58.61% | ||
71 Outperform | ¥29.20B | 9.60 | 4.78% | -0.18% | -39.24% | ||
61 Neutral | $18.02B | 12.77 | -0.74% | 3.01% | 1.30% | -13.03% | |
61 Neutral | ¥12.26B | 4.01 | 2.05% | -0.36% | -33.25% |